SHL Receives Great Response at the 2011 PDA in Basel

SHL successfully wrapped exhibition at the PDA’s "The Universe of Pre-filled Syringes and Injection Devices” event.

Deerfield Beach, FL, December 14, 2011 --( SHL successfully wrapped up this year’s exhibition at the PDA’s "The Universe of Pre-filled Syringes and Injection Devices" 2011 event held in Basel, Switzerland earlier last month. Great feedback was received from both visitors to the booth and those who attended the keynote session “Insight into Development and Manufacturing of Auto Injectors” presented by SHL Medical Europe's Vice President, Mats Persson and SHL Group’s Marketing Director, Steven Kaufman.

With various devices just recently launched on the market, SHL exhibited a large range of products at the show to ensure customers get a good overview of the company’s device portfolio. Some devices were available as demo devices to allow SHL staff to demonstrate the device mechanisms and to allow customers to get a hands-on feel for the devices actual usage. Featured devices included the SDI-MIX NIT, Molly and DAI. Dedicated videos showcasing the devices and how they operate also played at the booth.

The keynote presentation generated much buzz and stimulated many conversations amongst attendees. To request a copy of the presentation, please contact us at .

Overall, this year’s show was again a success and gave SHL the opportunity to share the company’s insights on the growing trends and demands of the drug delivery sector and better understand industry needs through in-depth conversations with several biopharmaceutical companies and partners.

Steven commented, “It was both an honor and a great experience for both Mats and I to speak at this year’s event and share with the audience our experiences. The interactions with the many attendees also helped us gain even more knowledge regarding the needs of this rapidly growing industry.”

About SHL
SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 1,800 staff globally (1000+ staff in Taiwan), with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.

SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.

Our organization consists of three distinct group companies:

SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies.

SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information visit or contact us at

SHL Media Contact
Steven R. Kaufman
Marketing Director

SHL Group (Scandinavian Health Group Ltd)
Steven Kaufman